The 3 A's of Medicine By Simon Douglas Murray, MD Twenty-five years ago I was told by my partner who had considerably more experience than I that the best way to build a medical practice was to follow the 3 “A’s of medicine”. In order of relevance they are availability, affability, and ability. Ability comes third because unless a doctor is available to patients so they come enough to like him, they would never know if he has any ability.
Pros and Cons of Echocardiography Technologies in Diagnosing Stress Cardiomyopathy By Gale Scott Stress cardiomyopathy is a unique cardiac syndrome in which transient left ventricular (LV) systolic dysfunction mimics acute myocardial infarction (AMI). It is usually brought on by acute emotional or physical stress (or both) and has 3 distinctive features: acute LV wall dysfunction, absence of significant obstructive coronary artery disease, and rapid improvement of LV systolic function within days or weeks.
Case Study: Preventing a Heart Attack in a Runner’s Twin By Gale Scott Silent coronary artery disease is often diagnosed too late to prevent a cardiac event. But in a case history involving twin brothers, a team from Liverpool Heart and Chest Hospital, Liverpool, UK shows that investigative imaging of an otherwise healthy man paid off.
Estimation of Cigarette Smoking–Attributable Morbidity in the US By Adam Hochron The fact that cigarette smoking is dangerous to a person’s health is not a new concept, but a recent study took a more direct view of just how much damage smokers in the United States do to themselves through what was described as “major medical conditions.”
Childhood Obesity and Risk of Allergy or Asthma By Adam Hochron A recent study looked at the relationship between obesity and a child’s risk of developing allergies or an asthmatic condition. Looking at what the authors perceived to be a growing trend of not only an increase in the number obese children but those suffering from new or worsening allergies the authors said they were looking for a link which could help treat the pediatric patients.
Efficacy of New Treatment Methods for AECOPD By Adam Hochron For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), the right treatment can make a world of difference in the management of their condition. A recent study looked at how effective inhaled budesonide and systemic methylprednisolone can be for those patients.
New Method Proposed for Levothyroxine Dose Estimation for Benign Disease By Jackie Syrop Patients’ body weight (BW) is the accepted way to calculate the starting dose of levothyroxine (LT4) after total thyroidectomy. However, Italian researchers sought to find a new way to improve the accuracy of the LT4 starting dose following total thyroidectomy by identifying other major predictive factors of LT4 requirement.
New Developments in Insulin Therapy for Type 2 Diabetes By Jackie Syrop In the American Journal of Medicine, Christopher Sorli, MD, of the Billings Clinic in Montana, reviewed new developments in insulin therapy for type 2 diabetes. He explained that insulin initiation often involved basal-only therapy in conjunction with existing oral glucose-lowering drugs.
Aging Associated with Defects in Beta Cell Ca2+ Dynamics By Jackie Syrop A group of international researchers led by Luosheng Li, MD, of the Rolf Luft Research Center for Diabetes and Endocrinology at the Karolinska Institutet, Karolinska University Hospital in Stockholm, Sweden, recently demonstrated that age-dependent decline in insulin secretion (and thus glucose homeostasis) from the beta cell in experimental mice models is associated with subtle changes in Ca2+ dynamics.
Gown Up or Isolate the Patient? Where’s the Evidence? By Jeannette Wick Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) have become significant and costly problems—so significant, in fact, that many patients have a basic knowledge of MRSA just from news reports. The Centers for Disease Control and Prevention (CDC) offer a large selection of free tools to educate the public about MRSA and VRE.
β-lactam, Macrolide or Both? Treating Community-Acquired Pneumonia By Jeannette Wick A non-inferiority study published in the October 6, 2014 issue of JAMA Internal Medicine looks at these drugs. The researchers report that prescribing β-lactam monotherapy may be as effective as the combination of a macrolide with a β-lactam in certain patients.
Triple Therapy for Hepatitis C Infection: Bacterial Infection Risk Rises, Changes By Jeannette Wick Patients who have HCV infection are at high risk for arthralgia, myalgias, pruritus, neuropathy, and decompensated livers. Until recently the sole available treatment was interferon. After the US Food and Drug Administration (FDA) approved ribavirin, patients who took ribavirin plus interferon responded better. Now, the FDA has approved a small selection of oral antivirals to treat hepatitis C.
Researchers Aim to Understand Extremity Pain Among Military By Jacquelyn Gray Chronic exertional compartment syndrome (CECS), a common condition among individuals who served in the military, is disproportionately untreated and misunderstood, according to research in Clinics in Sports Medicine, which aimed to highlight viable treatments.
Aiming for an “Acceptable” Pain Level for Children By Jacquelyn Gray For children, pain management regimens should aim for an acceptable level of pain, optimal mobilization, and minimal side effects, according to research published in Pediatric Anesthesia.